Amylin Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference & Goldman Sachs 33rd Annual Global Healthcar...
May 29 2012 - 4:15PM
Business Wire
Amylin Pharmaceuticals, Inc. (Nasdaq:AMLN) will be presenting at
the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5
at 1:30 p.m. ET/10:30 a.m. PT in New York and at the Goldman Sachs
33rd Annual Global Healthcare Conference on Wednesday, June 6 at
2:20 p.m. ET/11:20 a.m. PT in Rancho Palos Verdes, California. Mark
G. Foletta, senior vice president, finance and chief financial
officer of Amylin, will provide a corporate overview at the
Jeffries conference. Daniel M. Bradbury, president and chief
executive officer of Amylin, will provide a corporate overview at
the Goldman Sachs conference.
The presentations will be webcast through the “Investors”
section of Amylin’s corporate website at www.amylin.com and a
recording will be made available following the event. To access the
live webcast, please log on to Amylin's site approximately fifteen
minutes prior to the presentation to register and download any
necessary audio software.
About Amylin PharmaceuticalsAmylin Pharmaceuticals is a
biopharmaceutical company dedicated to improving lives of patients
through the discovery, development and commercialization of
innovative medicines. Amylin is committed to delivering novel
therapies that transform the way diabetes and other metabolic
disorders are treated. Amylin is headquartered in San Diego,
Calif., and has a commercial manufacturing facility in Ohio. More
information on Amylin Pharmaceuticals is available at
www.amylin.com.
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024